According to a case–control study published in Neurology, the expression of proinflammatory cytokines is elevated in the affected skin of patients with small-fiber neuropathy (SFN).

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Most burning feet treatments focus on preventing further nerve damage and reducing pain ... improve the neuropathy and symptoms. In other situations, such as many cases of small fiber neuropathy ...

Navega is pursuing a radically different approach for treatment of chronic pain associated ... intractable chronic pain conditions such primary erythromelalgia and small fiber neuropathy by ...

(A) This patient had a severe small-fiber sensory ... empty by degenerated unmyelinated fiber. (4) Denervated bands of Schwann cells. Multifocal diabetic neuropathy. Cross section of a paraffin ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Several factors influence the frequency and severity of chronic peripheral neuropathic pain, including type and dose of chemotherapy, pre-existing neuropathy, and the use of other drugs that can ...

As per the Centers for Disease Control and Prevention (CDC), Long COVID is defined as a chronic ... pain. Long COVID may also damage small nerve endings, a condition known as small-fiber ...

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ... neuropathy (CIPN), according to a meta-analysis published online in Regional Anesthesia & Pain ...

Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M ...

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence. (HealthDay News) — The pooled prevalence of chronic ...